Stem cell regeneration of degenerated intervertebral discs: Current status (Update)

Current Pain and Headache Reports

Volumn 17, Issue 12, 2013, Pages

  Gilbert, Hamish T J ^a   Hoyland, Judith A ^a   Richardson, Stephen M ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Adult mesenchymal stem cells; Cell based therapy; Degenerated intervertebral discs; Low back pain; Stem cell regeneration

Indexed keywords

ANESTHETIC AGENT; CORTICOSTEROID;

ADIPOSE TISSUE; ARTICLE; ARTICULAR CARTILAGE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BACKACHE; BONE MARROW; CARTILAGE CELL; CELL DIFFERENTIATION; CHRONIC PAIN; DISK PROSTHESIS; HUMAN; HYDROGEL; INTERVERTEBRAL DISK DEGENERATION; KINESIOTHERAPY; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; NUCLEUS PULPOSUS; PHYSIOTHERAPY; TARGET CELL; CELL COMMUNICATION; CELL CULTURE; COST OF ILLNESS; FEMALE; HEALTH CARE COST; INTERVERTEBRAL DISK; INTERVERTEBRAL DISK HERNIA; LOW BACK PAIN; MALE; METHODOLOGY; PATHOLOGY; REVIEW; STEM CELL; TISSUE ENGINEERING;

CELL COMMUNICATION; CELLS, CULTURED; COST OF ILLNESS; FEMALE; HEALTH CARE COSTS; HUMANS; INTERVERTEBRAL DISC; INTERVERTEBRAL DISC DISPLACEMENT; LOW BACK PAIN; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; STEM CELLS; TISSUE ENGINEERING;

EID: 84887278284     PISSN: 15313433     EISSN: 15343081     Source Type: Journal    
DOI: 10.1007/s11916-013-0377-0     Document Type: Article

References (103)

1. Stewart WF, Ricci JA, Chee E, Morganstein D, Lipton R. Lost productive time and cost due to common pain conditions in the US workforce. JAMA. 2003;290(18):2443-54. (Pubitemid 37430544)
2. Walker BF. The prevalence of low back pain: a systematic review of the literature from 1966 to 1998. J Spinal Disord. 2000;13(3):205-17. (Pubitemid 32201545)
3. Hoy D, Bain C, Williams G, March L, Brooks P, Blyth F, et al. A systematic review of the global prevalence of low back pain. Arthritis Rheum. 2012;64(6):2028-37.
4. Papageorgiou AC, Croft PR, Ferry S, Jayson MI, Silman AJ. Estimating the prevalence of low back pain in the general population. Evidence from the South Manchester Back Pain Survey. Spine (Phila Pa 1976). 1995;20(17):1889-94.
5. Harkness EF, Macfarlane GJ, Silman AJ, McBeth J. Is musculoskeletal pain more common now than 40 years ago?: two population-based cross-sectional studies. Rheumatology (Oxford). 2005;44(7):890-5. (Pubitemid 41511184)
6. Hershkovich O, Friedlander A, Gordon B, Arzi H, Derazne E, Tzur D, et al. Associations of body mass index and body height with low back pain in 829,791 adolescents. Am J Epidemiol. 2013;178(4):603-9.
7. Maniadakis N, Gray A. The economic burden of back pain in the UK. Pain. 2000;84(1):95-103.
8. Cheung KM, Karppinen J, Chan D, Ho DW, Song YQ, Sham P, et al. Prevalence and pattern of lumbar magnetic resonance imaging changes in a population study of one thousand forty-three individuals. Spine (Phila Pa 1976). 2009;34(9):934-40.
9. Samartzis D, Karppinen J, Mok F, Fong DY, Luk KD, Cheung KM. A population-based study of juvenile disc degeneration and its association with overweight and obesity, low back pain, and diminished functional status. J Bone Joint Surg Am. 2011;93(7):662-70.
10. Takatalo J, Karppinen J, Niinimaki J, Taimela S, Nayha S, Mutanen P, et al. Does lumbar disc degeneration on magnetic resonance imaging associate with low back symptom severity in young Finnish adults? Spine (Phila Pa 1976). 2011;36(25):2180-9.
11. Trout JJ, Buckwalter JA, Moore KC. Ultrastructure of the human intervertebral disc: II. Cells of the nucleus pulposus. Anat Rec. 1982;204(4):307-14. (Pubitemid 13225360)
12. Urban JP, McMullin JF. Swelling pressure of the inervertebral disc: influence of proteoglycan and collagen contents. Biorheology. 1985;22(2):145-57. (Pubitemid 15148783)
13. Brodin H. Paths of nutrition in articular cartilage and intervertebral discs. Acta Orthop Scand. 1955;24(3):177-83.
14. Adams MA, Roughley PJ. What is intervertebral disc degeneration, and what causes it? Spine (Phila Pa 1976). 2006;31(18):2151-61.
15. Mayer JE, Iatridis JC, Chan D, Qureshi SA, Gottesman O, Hecht AC. Genetic polymorphisms associated with intervertebral disc degeneration. Spine J. 2013;13(3):299-317.
16. Gopal D, Ho AL, Shah A, Chi JH. Molecular basis of intervertebral disc degeneration. Adv Exp Med Biol. 2012;760:114-33.
17. Le Maitre CL, Pockert A, Buttle DJ, Freemont AJ, Hoyland JA. Matrix synthesis and degradation in human intervertebral disc degeneration. Biochem Soc Trans. 2007;35(Pt 4):652-5. (Pubitemid 47310333)
18. Urban JP, Roberts S. Degeneration of the intervertebral disc. Arthritis Res Ther. 2003;5(3):120-30. (Pubitemid 36849758)
19. Podichetty VK. The aging spine: the role of inflammatory mediators in intervertebral disc degeneration. Cell Mol Biol (Noisy-le-grand). 2007;53(5):4-18. (Pubitemid 350164301)
20. Le Maitre CL, Freemont AJ, Hoyland JA. The role of interleukin-1 in the pathogenesis of human intervertebral disc degeneration. Arthritis Res Ther. 2005;7(4):R732-45.
21. Richardson SM, Doyle P, Minogue BM, Gnanalingham K, Hoyland JA. Increased expression of matrix metalloproteinase-10, nerve growth factor and substance P in the painful degenerate intervertebral disc. Arthritis Res Ther. 2009;11(4):R126.
22. Adams MA, McNally DS, Dolan P. 'Stress' distributions inside intervertebral discs. The effects of age and degeneration. J Bone Joint Surg Br. 1996;78(6):965-72. (Pubitemid 26392131)
23. Freemont AJ, Peacock TE, Goupille P, Hoyland JA, O'Brien J, Jayson MI. Nerve ingrowth into diseased intervertebral disc in chronic back pain. Lancet. 1997;350(9072):178-81. (Pubitemid 27303625)
24. Hughes SP, Freemont AJ, Hukins DW, McGregor AH, Roberts S. The pathogenesis of degeneration of the intervertebral disc and emerging therapies in the management of back pain. J Bone Joint Surg Br. 2012;94(10):1298-304.
25. Chan CC, Roberts CR, Steeves JD, Tetzlaff W. Aggrecan components differentially modulate nerve growth factor-responsive and neurotrophin-3- responsive dorsal root ganglion neurite growth. J Neurosci Res. 2008;86(3):581-92. (Pubitemid 351204471)
26. Johnson WE, Caterson B, Eisenstein SM, Hynds DL, Snow DM, Roberts S. Human intervertebral disc aggrecan inhibits nerve growth in vitro. Arthritis Rheum. 2002;46(10):2658-64. (Pubitemid 36118929)
27. Johnson WE, Caterson B, Eisenstein SM, Roberts S. Human intervertebral disc aggrecan inhibits endothelial cell adhesion and cell migration in vitro. Spine (Phila Pa 1976). 2005;30(10):1139-47. (Pubitemid 40695923)
28. Tolofari SK, Richardson SM, Freemont AJ, Hoyland JA. Expression of semaphorin 3A and its receptors in the human intervertebral disc: potential role in regulating neural ingrowth in the degenerate intervertebral disc. Arthritis Res Ther. 2010;12(1):R1.
29. Purmessur D, Freemont AJ, Hoyland JA. Expression and regulation of neurotrophins in the nondegenerate and degenerate human intervertebral disc. Arthritis Res Ther. 2008;10(4):R99.
30. Richardson SM, Purmessur D, Baird P, Probyn B, Freemont AJ, Hoyland JA. Degenerate human nucleus pulposus cells promote neurite outgrowth in neural cells. PLoS One. 2012;7(10):e47735.
31. Ali R, Le Maitre CL, Richardson SM, Hoyland JA, Freemont AJ. Connective tissue growth factor expression in human intervertebral disc: implications for angiogenesis in intervertebral disc degeneration. Biotech Histochem. 2008;83(5):239-45. (Pubitemid 352754715)
32. Roelofs PD, Deyo RA, Koes BW, Scholten RJ, van Tulder MW. Nonsteroidal anti-inflammatory drugs for low back pain: an updated Cochrane review. Spine (Phila Pa 1976). 2008;33(16):1766-74.
33. Staal JB, de Bie RA, de Vet HC, Hildebrandt J, Nelemans P. Injection therapy for subacute and chronic low back pain: an updated Cochrane review. Spine (Phila Pa 1976). 2009;34(1):49-59.
34. Vaccaro AR, Patel T, Fischgrund J, Anderson DG, Truumees E, Herkowitz H, et al. A pilot safety and efficacy study of OP-1 putty (rhBMP-7) as an adjunct to iliac crest autograft in posterolateral lumbar fusions. Eur Spine J. 2003;12(5):495-500. (Pubitemid 37409948)
35. Southwick WO, Robinson RA. Surgical approaches to the vertebral bodies in the cervical and lumbar regions. J Bone Joint Surg Am. 1957;39-A(3):631-44.
36. Lewis G. Viscoelastic properties of injectable bone cements for orthopaedic applications: state-of-the-art review. J Biomed Mater Res B Appl Biomater. 2011;98(1):171-91.
37. Ghiselli G, Wang JC, Bhatia NN, Hsu WK, Dawson EG. Adjacent segment degeneration in the lumbar spine. J Bone Joint Surg Am. 2004;86-A(7):1497-503. (Pubitemid 38886539)
38. Guyer RD, McAfee PC, Banco RJ, Bitan FD, Cappuccino A, Geisler FH, et al. Prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of lumbar total disc replacement with the CHARITE artificial disc versus lumbar fusion: five-year follow-up. Spine J. 2009;9(5):374-86.
39. Zigler J, Delamarter R, Spivak JM, Linovitz RJ, Danielson 3rd GO, Haider TT, et al. Results of the prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of the ProDisc-L total disc replacement versus circumferential fusion for the treatment of 1-level degenerative disc disease. Spine (Phila Pa 1976). 2007;32(11):1155-62. discussion 63. (Pubitemid 46743014)
40. Sasso RC, Foulk DM, Hahn M. Prospective, randomized trial of metal-on-metal artificial lumbar disc replacement: initial results for treatment of discogenic pain. Spine (Phila Pa 1976). 2008;33(2):123-31.
41. Zigler JE, Glenn J, Delamarter RB. Five-year adjacent-level degenerative changes in patients with single-level disease treated using lumbar total disc replacement with ProDisc-L versus circumferential fusion. J Neurosurg Spine. 2012;17(6):504-11.
42. Kostuik JP. Complications and surgical revision for failed disc arthroplasty. Spine J. 2004;4(6 Suppl):289S-91S. (Pubitemid 39497316)
43. Thompson JP, Oegema Jr TR, Bradford DS. Stimulation of mature canine intervertebral disc by growth factors. Spine (Phila Pa 1976). 1991;16(3):253-60.
44. Gruber HE, Fisher Jr EC, Desai B, Stasky AA, Hoelscher G, Hanley Jr EN. Human intervertebral disc cells from the annulus: three-dimensional culture in agarose or alginate and responsiveness to TGF-beta1. Exp Cell Res. 1997;235(1):13-21. (Pubitemid 27381676)
45. Osada R, Ohshima H, Ishihara H, Yudoh K, Sakai K, Matsui H, et al. Autocrine/paracrine mechanism of insulin-like growth factor-1 secretion, and the effect of insulin-like growth factor-1 on proteoglycan synthesis in bovine intervertebral discs. J Orthop Res. 1996;14(5):690-9. (Pubitemid 26376511)
46. Walsh AJ, Bradford DS, Lotz JC. In vivo growth factor treatment of degenerated intervertebral discs. Spine (Phila Pa 1976). 2004;29(2):156-63. (Pubitemid 38112496)
47. Fei QM, Jiang XX, Chen TY, Li J, Murakami H, Tsai KJ, et al. Changes with age and the effect of recombinant human BMP-2 on proteoglycan and collagen gene expression in rabbit anulus fibrosus cells. Acta Biochim Biophys Sin (Shanghai). 2006;38(11):773-9. (Pubitemid 44749582)
48. Zhang Y, Phillips FM, Thonar EJ, Oegema T, An HS, Roman-Blas JA, et al. Cell therapy using articular chondrocytes overexpressing BMP-7 or BMP-10 in a rabbit disc organ culture model. Spine (Phila Pa 1976). 2008;33(8):831-8. (Pubitemid 351533849)
49. Zhang Y, Anderson DG, Phillips FM, Thonar EJ, He TC, Pietryla D, et al. Comparative effects of bone morphogenetic proteins and Sox9 overexpression on matrix accumulation by bovine anulus fibrosus cells: implications for anular repair. Spine (Phila Pa 1976). 2007;32(23):2515-20. (Pubitemid 350059476)
50. Moon SH, Nishida K, Gilbertson LG, Lee HM, Kim H, Hall RA, et al. Biologic response of human intervertebral disc cells to gene therapy cocktail. Spine (Phila Pa 1976). 2008;33(17):1850-5.
51. Imai Y, Okuma M, An HS, Nakagawa K, Yamada M, Muehleman C, et al. Restoration of disc height loss by recombinant human osteogenic protein-1 injection into intervertebral discs undergoing degeneration induced by an intradiscal injection of chondroitinase ABC. Spine (Phila Pa 1976). 2007;32(11):1197-205. (Pubitemid 46743020)
52. Gruber HE, Hanley Jr EN. Analysis of aging and degeneration of the human intervertebral disc. Comparison of surgical specimens with normal controls. Spine (Phila Pa 1976). 1998;23(7):751-7. (Pubitemid 28169196)
53. Larson 3rd JW, Levicoff EA, Gilbertson LG, Kang JD. Biologic modification of animal models of intervertebral disc degeneration. J Bone Joint Surg Am. 2006;88 Suppl 2:83-7.
54. Masuda K. Biological repair of the degenerated intervertebral disc by the injection of growth factors. Eur Spine J. 2008;17 Suppl 4:441-51.
55. Hohaus C, Ganey TM, Minkus Y, Meisel HJ. Cell transplantation in lumbar spine disc degeneration disease. Eur Spine J. 2008;17 Suppl 4:492-503.
56. Meisel HJ, Siodla V, Ganey T, Minkus Y, Hutton WC, Alasevic OJ. Clinical experience in cell-based therapeutics: disc chondrocyte transplantation A treatment for degenerated or damaged intervertebral disc. Biomol Eng. 2007;24(1):5-21. (Pubitemid 46216157)
57. Carragee EJ, Don AS, Hurwitz EL, Cuellar JM, Carrino JA, Herzog R. ISSLS prize winner: does discography cause accelerated progression of degeneration changes in the lumbar disc: a ten-year matched cohort study. Spine (Phila Pa 1976). 2009;34(21):2338-45.
58. Sive JI, Baird P, Jeziorsk M, Watkins A, Hoyland JA, Freemont AJ. Expression of chondrocyte markers by cells of normal and degenerate intervertebral discs. Mol Pathol. 2002;55(2):91-7. (Pubitemid 34293410)
59. Le Maitre CL, Freemont AJ, Hoyland JA. Accelerated cellular senescence in degenerate intervertebral discs: a possible role in the pathogenesis of intervertebral disc degeneration. Arthritis Res Ther. 2007;9(3):R45.
60. Coric D, Pettine K, Sumich A, Boltes MO. Prospective study of disc repair with allogeneic chondrocytes presented at the 2012 Joint Spine Section Meeting. J Neurosurg Spine. 2013;18(1):85-95.
61. Richardson SM, Hughes N, Hunt JA, Freemont AJ, Hoyland JA. Human mesenchymal stem cell differentiation to NP-like cells in chitosan- glycerophosphate hydrogels. Biomaterials. 2008;29(1):85-93. (Pubitemid 47599659)
62. Henriksson H, Thornemo M, Karlsson C, Hagg O, Junevik K, Lindahl A, et al. Identification of cell proliferation zones, progenitor cells and a potential stem cell niche in the intervertebral disc region: a study in four species. Spine (Phila Pa 1976). 2009;34(21):2278-87.
63. Brisby H, Papadimitriou N, Brantsing C, Bergh P, Lindahl A, Barreto Henriksson H. The presence of local mesenchymal progenitor cells in human degenerated intervertebral discs and possibilities to influence these in vitro: a descriptive study in humans. Stem Cells Dev. 2013;22(5):804-14.
64. Risbud MV, Guttapalli A, Tsai TT, Lee JY, Danielson KG, Vaccaro AR, et al. Evidence for skeletal progenitor cells in the degenerate human intervertebral disc. Spine (Phila Pa 1976). 2007;32(23):2537-44. (Pubitemid 350059479)
65. Sakai D, Nakamura Y, Nakai T, Mishima T, Kato S, Grad S, et al. Exhaustion of nucleus pulposus progenitor cells with ageing and degeneration of the intervertebral disc. Nat Commun. 2012;3:1264. Identification of nucleus pulposus progenitor cell population within the intervertebral disc (IVD) that may have the potential to regenerate the IVD. The number of these precursor cells is shown to decrease with advancing degeneration and age, suggesting a decrease in the endogenous repair mechanism and identifying a potential clinical marker for intervertebral disc degeneration.
66. Stoyanov JV, Gantenbein-Ritter B, Bertolo A, Aebli N, Baur M, Alini M, et al. Role of hypoxia and growth and differentiation factor-5 on differentiation of human mesenchymal stem cells towards intervertebral nucleus pulposus-like cells. Eur Cell Mater. 2011;21:533-47.
67. Minogue BM, Richardson SM, Zeef LA, Freemont AJ, Hoyland JA. Characterization of the human nucleus pulposus cell phenotype and evaluation of novel marker gene expression to define adult stem cell differentiation. Arthritis Rheum. 2010;62(12):3695-705. First study to identify a panel of markers specific to human nucleus pulposus (NP) cells, showing that there are species differences in phenotype. Demonstrates that such markers can be used to define appropriate stem cell differentiation to an NP-like cell, which has important implications for tissue engineering of the intervertebral disc. Also indicates that adipose derived mesenchymal stem cells may be the more appropriate cell type to use for intervertebral disc regeneration.
68. Sakai D, Mochida J, Iwashina T, Hiyama A, Omi H, Imai M, et al. Regenerative effects of transplanting mesenchymal stem cells embedded in atelocollagen to the degenerated intervertebral disc. Biomaterials. 2006;27(3):335-45. (Pubitemid 41457236)
69. Strassburg S, Richardson SM, Freemont AJ, Hoyland JA. Co-culture induces mesenchymal stem cell differentiation and modulation of the degenerate human nucleus pulposus cell phenotype. Regen Med. 2010;5(5):701-11.
70. Tao F, Li F, Li G, Pan F. Differentiation of mesenchymal stem cells into nucleus pulposus cells in vitro. J Huazhong Univ Sci Technolog Med Sci. 2008;28(2):156-8.
71. Orozco L, Soler R, Morera C, Alberca M, Sanchez A, Garcia-Sancho J. Intervertebral disc repair by autologous mesenchymal bone marrow cells: a pilot study. Transplantation. 2011;92(7):822-8. The first human clinical study investigating the outcome of autologous mesenchymal stem cell implantation into degenerate intervertebral discs. Preliminary evidence to suggest benefits, in terms of pain relief (comparable with that reported for vertebral body fusion).
72. Henriksson HB, Svanvik T, Jonsson M, Hagman M, Horn M, Lindahl A, et al. Transplantation of human mesenchymal stems cells into intervertebral discs in a xenogeneic porcine model. Spine (Phila Pa 1976). 2009;34(2):141-8.
73. Mwale F, Roughley P, Antoniou J. Distinction between the extracellular matrix of the nucleus pulposus and hyaline cartilage: a requisite for tissue engineering of intervertebral disc. Eur Cell Mater. 2004;8:58-63. discussion -4.
74. Henriksson HB, Brisby H. Development and regeneration potential of the mammalian intervertebral disc. Cells Tissues Organs. 2013;197(1):1-13.
75. Ludwinski FE, Gnanalingham K, Richardson SM, Hoyland JA. Understanding the native nucleus pulposus cell phenotype has important implications for intervertebral disc regeneration strategies. Regen Med. 2013;8(1):75-87.
76. Smith LJ, Nerurkar NL, Choi KS, Harfe BD, Elliott DM. Degeneration and regeneration of the intervertebral disc: lessons from development. Dis Model Mech. 2011;4(1):31-41.
77. Minogue BM, Richardson SM, Zeef LA, Freemont AJ, Hoyland JA. Transcriptional profiling of bovine intervertebral disc cells: implications for identification of normal and degenerate human intervertebral disc cell phenotypes. Arthritis Res Ther. 2010;12(1):R22.
78. Chun HJ, Kim YS, Kim BK, Kim EH, Kim JH, Do BR, et al. Transplantation of human adipose-derived stem cells in a rabbit model of traumatic degeneration of lumbar discs. World Neurosurg. 2012;78(3-4):364-71. Evidence to suggest mesenchymal stem cells derived from adipose tissue could be a suitable cell type for the regeneration of the intervertebral disc.
79. Johnstone B, Hering TM, Caplan AI, Goldberg VM, Yoo JU. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res. 1998;238(1):265-72. (Pubitemid 28366150)
80. Chiou M, Xu Y, Longaker MT. Mitogenic and chondrogenic effects of fibroblast growth factor-2 in adipose-derived mesenchymal cells. Biochem Biophys Res Commun. 2006;343(2):644-52.
81. Knippenberg M, Helder MN, Zandieh Doulabi B, Wuisman PI, Klein-Nulend J. Osteogenesis versus chondrogenesis by BMP-2 and BMP-7 in adipose stem cells. Biochem Biophys Res Commun. 2006;342(3):902-8. (Pubitemid 43320483)
82. Longobardi L, O'Rear L, Aakula S, Johnstone B, Shimer K, Chytil A, et al. Effect of IGF-I in the chondrogenesis of bone marrow mesenchymal stem cells in the presence or absence of TGF-beta signaling. J Bone Miner Res. 2006;21(4):626-36.
83. Sun Z, Liu ZH, Zhao XH, Sun L, Chen YF, Zhang WL, et al. Impact of direct cell co-cultures on human adipose-derived stromal cells and nucleus pulposus cells. J Orthop Res. 2013. doi: 10.1002/jor.22439.
84. Strassburg S, Hodson NW, Hill PI, Richardson SM, Hoyland JA. Bi-directional exchange of membrane components occurs during co-culture of mesenchymal stem cells and nucleus pulposus cells. PLoS One. 2012;7(3):e33739.
85. Iatridis JC, Nicoll SB, Michalek AJ, Walter BA, Gupta MS. Role of biomechanics in intervertebral disc degeneration and regenerative therapies: what needs repairing in the disc and what are promising biomaterials for its repair? Spine J. 2013;13(3):243-62.
86. Frith JE, Cameron AR, Menzies DJ, Ghosh P, Whitehead DL, Gronthos S, et al. An injectable hydrogel incorporating mesenchymal precursor cells and pentosan polysulphate for intervertebral disc regeneration. Biomaterials. 2013. doi: 10.1016/j.biomaterials.2013.08.072.
87. Cheng YH, Yang SH, Liu CC, Gefen A, Lin FH. Thermosensitive hydrogel made of ferulic acid-gelatin and chitosan glycerophosphate. Carbohydr Polym. 2013;92(2):1512-9.
88. Francisco AT, Mancino RJ, Bowles RD, Brunger JM, Tainter DM, Chen YT, et al. Injectable laminin-functionalized hydrogel for nucleus pulposus regeneration. Biomaterials. 2013;34(30):7381-8.
89. Calderon L, Collin E, Velasco-Bayon D, Murphy M, O'Halloran D, Pandit A. Type II collagen-hyaluronan hydrogel-a step towards a scaffold for intervertebral disc tissue engineering. Eur Cell Mater. 2010;20:134-48.
90. Peroglio M, Eglin D, Benneker LM, Alini M, Grad S. Thermoreversible hyaluronan-based hydrogel supports in vitro and ex vivo disc-like differentiation of human mesenchymal stem cells. Spine J. 2013. doi: 10.1016/j.spinee.2013.05.029.
91. Bartels EM, Fairbank JC, Winlove CP, Urban JP. Oxygen and lactate concentrations measured in vivo in the intervertebral discs of patients with scoliosis and back pain. Spine (Phila Pa 1976). 1998;23(1):1-7. discussion 8.
92. Diamant B, Karlsson J, Nachemson A. Correlation between lactate levels and pH in discs of patients with lumbar rhizopathies. Experientia. 1968;24(12):1195-6.
93. Rodriguez AG, Rodriguez-Soto AE, Burghardt AJ, Berven S, Majumdar S, Lotz JC. Morphology of the human vertebral endplate. J Orthop Res. 2012;30(2):280-7.
94. Roberts S, Urban JP, Evans H, Eisenstein SM. Transport properties of the human cartilage endplate in relation to its composition and calcification. Spine (Phila Pa 1976). 1996;21(4):415-20. (Pubitemid 26067848)
95. Battie MC, Videman T, Gill K, Moneta GB, Nyman R, Kaprio J, et al. 1991 Volvo Award in clinical sciences. Smoking and lumbar intervertebral disc degeneration: an MRI study of identical twins. Spine (Phila Pa 1976). 1991;16(9):1015-21.
96. Urban JP, Maroudas A. Swelling of the intervertebral disc in vitro. Connect Tissue Res. 1981;9(1):1-10.
97. Gilbert HT, Hoyland JA, Millward-Sadler SJ. The response of human anulus fibrosus cells to cyclic tensile strain is frequency-dependent and altered with disc degeneration. Arthritis Rheum. 2010;62(11):3385-94.
98. Wuertz K, Godburn K, Neidlinger-Wilke C, Urban J, Iatridis JC. Behavior of mesenchymal stem cells in the chemical microenvironment of the intervertebral disc. Spine (Phila Pa 1976). 2008;33(17):1843-9.
99. Liang C, Li H, Tao Y, Zhou X, Li F, Chen G, et al. Responses of human adipose-derived mesenchymal stem cells to chemical microenvironment of the intervertebral disc. J Transl Med. 2012;10:49.
100. Korecki CL, MacLean JJ, Iatridis JC. Characterization of an in vitro intervertebral disc organ culture system. Eur Spine J. 2007;16(7):1029-37. (Pubitemid 47063470)
101. Gawri R, Mwale F, Ouellet J, Roughley PJ, Steffen T, Antoniou J, et al. Development of an organ culture system for long-term survival of the intact human intervertebral disc. Spine (Phila Pa 1976). 2011;36(22):1835-42.
102. Yoshikawa T, Ueda Y, Miyazaki K, Koizumi M, Takakura Y. Disc regeneration therapy using marrow mesenchymal cell transplantation: a report of two case studies. Spine (Phila Pa 1976). 2010;35(11):E475-80.
103. Vadala G, Sowa G, Hubert M, Gilbertson LG, Denaro V, Kang JD. Mesenchymal stem cells injection in degenerated intervertebral disc: cell leakage may induce osteophyte formation. J Tissue Eng Regen Med. 2012;6(5):348-55.